Item 5.07 Submission of Matters to a Vote of Security Holders.

At the 2022 annual meeting of Global Medical REIT Inc. (the "Company"), the Company's stockholders: (i) elected the eight nominated directors to the Company's Board of Directors, each to serve until the Company's 2023 annual meeting of stockholders and until her or his successor is duly elected and qualifies, (ii) approved, on an advisory basis, the compensation of the Company's named executive officers, and (iii) ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022. The full results of the matters voted on at the 2022 annual meeting of stockholders are set forth below:

Proposal 1 - Election of Directors:





Nominee for Director      For        Against    Abstain   Broker Non-Votes
Jeffrey M. Busch       42,941,919   2,277,422   150,259      10,577,481
Matthew Cypher         44,325,784    986,860    56,956       10,577,481
Ronald Marston         44,208,099   1,114,995   46,503       10,577,484
Roscoe Moore, Jr.      44,300,766   1,007,844   60,989       10,577,482
Henry E. Cole          44,918,473    402,754    48,374       10,577,480
Zhang Huiqi            45,081,576    236,932    51,091       10,577,482
Paula R. Crowley       45,101,550    213,263    54,787       10,577,481
Lori Wittman           44,333,467    982,056    54,077       10,577,481

Proposal 2 - Advisory Vote on Named Executive Officer Compensation:





   For       Against   Abstain   Broker Non-Votes
44,326,258   818,018   225,318      10,577,487




Proposal 3 - Ratification of Appointment of Independent Registered Public
Accounting Firm:



   For       Against   Abstain   Broker Non-Votes
55,785,212   84,797    77,072           0

Item 7.01 Regulation FD Disclosure.

On May 13, 2022, the Company updated a presentation concerning the Company on its website, www.globalmedicalreit.com, on the "Investors" page. A copy of the investor presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein solely for purposes of this Item 7.01 disclosure. Such investor presentation shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in this Item 7.01, as well as Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.





(d)  Exhibits




Exhibit No.   Description
   99.1         Investor Presentation dated May 13, 2022.

104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses